Royal Bank Of Canada Harmony Biosciences Holdings, Inc. Transaction History

Royal Bank Of Canada

$479 Billion
Q4 2024

A detailed history of Royal Bank Of Canada transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 22,319 shares of HRMY stock, worth $762,863. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,319

Previous 4,684 376.49%

Holding current value

$762,863

Previous $187,000 310.16%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$31.86 - $41.49 $561,851 - $731,676	17,635 Added 376.49%	22,319 $767,000
Q3 2024 Nov 14, 2024	SELL	$30.0 - $39.95 $221,520 - $294,990	-7,384 Reduced 61.19%	4,684 $187,000
Q2 2024 Aug 14, 2024	SELL	$28.81 - $33.01 $470,092 - $538,624	-16,317 Reduced 57.48%	12,068 $364,000
Q1 2024 Nov 05, 2024	BUY	$29.93 - $35.06 $488,367 - $572,074	16,317 Added 135.21%	28,385 $953,000
Q1 2024 May 15, 2024	SELL	$29.93 - $35.06 $129,836 - $152,090	-4,338 Reduced 13.26%	28,385 $953,000
Q4 2023 Feb 14, 2024	BUY	$19.2 - $33.78 $269,126 - $473,494	14,017 Added 74.93%	32,723 $1.06 Million
Q3 2023 Nov 14, 2023	BUY	$31.89 - $39.03 $219,052 - $268,097	6,869 Added 58.03%	18,706 $612,000
Q2 2023 Aug 14, 2023	BUY	$30.5 - $37.4 $123,921 - $151,956	4,063 Added 52.26%	11,837 $416,000
Q1 2023 May 15, 2023	SELL	$30.8 - $53.92 $83,314 - $145,853	-2,705 Reduced 25.81%	7,774 $253,000
Q4 2022 Feb 14, 2023	BUY	$45.4 - $60.91 $212,426 - $284,997	4,679 Added 80.67%	10,479 $577,000
Q3 2022 Nov 14, 2022	BUY	$42.06 - $55.45 $209,584 - $276,307	4,983 Added 609.91%	5,800 $257,000
Q2 2022 Aug 15, 2022	SELL	$33.54 - $52.15 $47,794 - $74,313	-1,425 Reduced 63.56%	817 $40,000
Q1 2022 May 16, 2022	SELL	$33.14 - $51.13 $86,197 - $132,989	-2,601 Reduced 53.71%	2,242 $109,000
Q4 2021 Feb 14, 2022	BUY	$34.09 - $43.91 $54,066 - $69,641	1,586 Added 48.7%	4,843 $206,000
Q3 2021 Nov 15, 2021	BUY	$25.68 - $38.61 $24,755 - $37,220	964 Added 42.04%	3,257 $125,000
Q2 2021 Aug 16, 2021	BUY	$25.96 - $33.44 $59,526 - $76,677	2,293 New	2,293 $65,000

Others Institutions Holding HRMY

# of Institutions

255

Shares Held

46.6M

Call Options Held

119K

Put Options Held

50K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.02B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Harmony Biosciences Holdings, Inc. Transaction History